Biodistribution of HPMA Copolymer-Aminohexylgeldanamycin-RGDfK Conjugates for Prostate Cancer Drug Delivery-Reference-Cited by-同舟云学术

Biodistribution of HPMA Copolymer-Aminohexylgeldanamycin-RGDfK Conjugates for Prostate Cancer Drug Delivery

Published:2009-10-01 Issue:6 Volume:6 Page:1836-1847
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Borgman Mark P.¹,Aras Omer¹,Geyser-Stoops Sandra¹,Sausville Edward A.¹,Ghandehari Hamidreza¹

Affiliation:

1. Department of Pharmaceutical Sciences, Center for Nanomedicine and Cellular Delivery, Department of Diagnostic Radiology and Nuclear Medicine, and Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland 21201, and Department of Pharmaceutics and Pharmaceutical Chemistry, Department of Bioengineering, and Center for Nanomedicine, Nano Institute of Utah, University of Utah, Salt Lake City, Utah 84108

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/mp900134c

Reference48 articles.

1. Polymer conjugates as anticancer nanomedicines

2. Polymer-drug conjugates: Recent development in clinical oncology

3. HPMA copolymer–anticancer drug conjugates: design, activity, and mechanism of action

4. Polymeric conjugates of mono- and bi-cyclic αVβ3 binding peptides for tumor targeting

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel strategies for enhanced fluorescence visualization of glioblastoma tumors based on HPMA copolymers conjugated with tumor targeting and/or cell‐penetrating peptides;VIEW;2024-04-24

2. HPMA copolymer-collagen hybridizing peptide conjugates targeted to breast tumor extracellular matrix;Journal of Controlled Release;2023-01

3. A Review on Exploring the Opportunities of Polymer Drug Conjugated Systems for Targeted Cancer Treatment;Current Drug Delivery;2023-01

4. Targeted nanomedicine modalities for prostate cancer treatment;Drug Resistance Updates;2021-05

5. Nanoparticles and prostate cancer;Nano Drug Delivery Strategies for the Treatment of Cancers;2021